Literature DB >> 3221865

Evolution, expression, and chromosomal location of a novel receptor tyrosine kinase gene, eph.

Y Maru1, H Hirai, M C Yoshida, F Takaku.   

Abstract

Partial sequence analysis of the genomic eph locus revealed that the splicing points of kinase domain-encoding exons were completely distinct from those of the other protein tyrosine kinase members reported, suggesting that this is the earliest evolutionary split within this family. In Northern (RNA) blot analysis, the eph gene was expressed in liver, lung, kidney, and testis of rat, and screening of 25 human cancers of various cell types showed preferential expression in cells of epithelial origin. Overexpression of eph mRNA was found in a hepatoma and a lung cancer without gene amplification. Comparison of cDNA sequences derived from a normal liver and a hepatoma that overproduces eph mRNA demonstrated that two of them were completely identical throughout the transmembrane to the carboxy-terminal portions. Southern blot analysis of DNAs from human-mouse hybrid clones with an eph probe showed that this gene was present on human chromosome 7.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3221865      PMCID: PMC365435          DOI: 10.1128/mcb.8.9.3770-3776.1988

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  79 in total

1.  Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line.

Authors:  S Fukushige; K Matsubara; M Yoshida; M Sasaki; T Suzuki; K Semba; K Toyoshima; T Yamamoto
Journal:  Mol Cell Biol       Date:  1986-03       Impact factor: 4.272

2.  Isolation and oncogenic potential of a novel human src-like gene.

Authors:  T Kawakami; C Y Pennington; K C Robbins
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

3.  Structure, expression, and chromosomal location of the human c-fgr gene.

Authors:  M Nishizawa; K Semba; M C Yoshida; T Yamamoto; M Sasaki; K Toyoshima
Journal:  Mol Cell Biol       Date:  1986-02       Impact factor: 4.272

4.  Isolation of chicken cellular DNA sequences with homology to the region of viral oncogenes that encodes the tyrosine kinase domain.

Authors:  D A Foster; J B Levy; G Q Daley; M C Simon; H Hanafusa
Journal:  Mol Cell Biol       Date:  1986-01       Impact factor: 4.272

5.  Characterization of an activated human ros gene.

Authors:  C Birchmeier; D Birnbaum; G Waitches; O Fasano; M Wigler
Journal:  Mol Cell Biol       Date:  1986-09       Impact factor: 4.272

6.  "Replacement" of COOH-terminal truncation of v-fms with c-fms sequences markedly reduces transformation potential.

Authors:  P J Browning; H F Bunn; A Cline; M Shuman; A W Nienhuis
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

7.  New M13 vectors for cloning.

Authors:  J Messing
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

8.  Proto-oncogene c-ros codes for a molecule with structural features common to those of growth factor receptors and displays tissue specific and developmentally regulated expression.

Authors:  W S Neckameyer; M Shibuya; M T Hsu; L H Wang
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

9.  A novel human gene closely related to the abl proto-oncogene.

Authors:  G D Kruh; C R King; M H Kraus; N C Popescu; S C Amsbaugh; W O McBride; S A Aaronson
Journal:  Science       Date:  1986-12-19       Impact factor: 47.728

10.  Structure and sequence of the cellular gene homologous to the RSV src gene and the mechanism for generating the transforming virus.

Authors:  T Takeya; H Hanafusa
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

View more
  14 in total

1.  Two point mutations in the transmembrane domain of P68gag-ros inactive its transforming activity and cause a delay in membrane association.

Authors:  S M Jong; L H Wang
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

2.  cDNA cloning and characterization of eck, an epithelial cell receptor protein-tyrosine kinase in the eph/elk family of protein kinases.

Authors:  R A Lindberg; T Hunter
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

3.  Identification of chicken embryo kinase 5, a developmentally regulated receptor-type tyrosine kinase of the Eph family.

Authors:  E B Pasquale
Journal:  Cell Regul       Date:  1991-07

Review 4.  Kinase inhibitors in cancer therapy: a look ahead.

Authors:  H H Sedlacek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

5.  Ephrin-A1 expression contributes to the malignant characteristics of {alpha}-fetoprotein producing hepatocellular carcinoma.

Authors:  H Iida; M Honda; H F Kawai; T Yamashita; Y Shirota; B-C Wang; H Miao; S Kaneko
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

Review 6.  Clinical relevance of Ephs and ephrins in cancer: lessons from breast, colorectal, and lung cancer profiling.

Authors:  Dana M Brantley-Sieders
Journal:  Semin Cell Dev Biol       Date:  2011-10-21       Impact factor: 7.727

7.  Characterization of elk, a brain-specific receptor tyrosine kinase.

Authors:  V Lhoták; P Greer; K Letwin; T Pawson
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

8.  Molecular cloning of HEK, the gene encoding a receptor tyrosine kinase expressed by human lymphoid tumor cell lines.

Authors:  I P Wicks; D Wilkinson; E Salvaris; A W Boyd
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

9.  Associations of the Top 20 Alzheimer Disease Risk Variants With Brain Amyloidosis.

Authors:  Liana G Apostolova; Shannon L Risacher; Tugce Duran; Eddie C Stage; Naira Goukasian; John D West; Triet M Do; Jonathan Grotts; Holly Wilhalme; Kwangsik Nho; Meredith Phillips; David Elashoff; Andrew J Saykin
Journal:  JAMA Neurol       Date:  2018-03-01       Impact factor: 18.302

Review 10.  eph, the largest known family of putative growth factor receptors.

Authors:  N L Tuzi; W J Gullick
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.